Gibson, Dunn & Crutcher LLP advised Biosynth Carbosynth, a portfolio company of the KKR Health Care Growth fund, in its acquisition of Pepscan Therapeutics and Pepscan...
Biosynth Carbosynth’s Acquisition of Pepscan
+Simple’s €90 Million Funding
Gibson, Dunn & Crutcher LLP acted for KKR Next Generation Technology on its growth investment in +Simple, assisted by Scotto Partners. McDermott represented Tikehau. Hogan Lovells...